Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:993-1006
Published online before print August 13, 2007, doi: 10.1161/CIRCULATIONAHA.106.682302
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Data Supplement
Right arrow Correction (v118,pe84)
Right arrow All Versions of this Article:
116/9/993    most recent
CIRCULATIONAHA.106.682302v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rao, F.
Right arrow Articles by O’Connor, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rao, F.
Right arrow Articles by O’Connor, D. T.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
*Genetics Home Reference
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Genomics
Right arrow Hypertension - basic studies
Right arrow Clinical Studies
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Genetics of cardiovascular disease

(Circulation. 2007;116:993-1006.)
© 2007 American Heart Association, Inc.


Genetics

Tyrosine Hydroxylase, the Rate-Limiting Enzyme in Catecholamine Biosynthesis

Discovery of Common Human Genetic Variants Governing Transcription, Autonomic Activity, and Blood Pressure In Vivo

Fangwen Rao, MM*; Lian Zhang, MD*; Jennifer Wessel, PhD; Kuixing Zhang, MD, PhD; Gen Wen, MD, PhD; Brian P. Kennedy, PhD; Brinda K. Rana, PhD; Madhusudan Das, PhD; Juan L. Rodriguez-Flores, MS; Douglas W. Smith, PhD; Peter E. Cadman, MD; Rany M. Salem, MPH; Sushil K. Mahata, PhD; Nicholas J. Schork, PhD; Laurent Taupenot, PhD; Michael G. Ziegler, MD; Daniel T. O’Connor, MD

From the Departments of Medicine (F.R., L.Z., K.Z., G.W., B.P.K., M.D., J.L.R.-F., P.E.C., R.M.S., S.K.M., L.T., M.G.Z., D.T.O.), Pharmacology (D.T.O.), Psychiatry (J.W., B.K.R., N.J.R.), and Biology (D.W.S.) and the Center for Human Genetics and Genomics (N.J.S., D.T.O.), University of California at San Diego, and the VA San Diego Healthcare System (S.K.M., D.T.O.), San Diego, Calif.

Correspondence to Daniel T. O’Connor, MD, Michael G. Ziegler, MD, or Laurent Taupenot, PhD, Department of Medicine and CHGG, UCSD School of Medicine, 9500 Gilman Dr, La Jolla, CA 92093–0838. E-mail doconnor{at}ucsd.edu, mziegler@ucsd.edu, or ltaupenot@ucsd.edu

Received January 18, 2007; accepted May 8, 2007.

Background— Tyrosine hydroxylase (TH) is the rate-limiting enzyme in catecholamine biosynthesis. Does common genetic variation at human TH alter autonomic activity and predispose to cardiovascular disease? We undertook systematic polymorphism discovery at the TH locus and then tested variants for contributions to sympathetic function and blood pressure.

Methods and Results— We resequenced 80 ethnically diverse individuals across the TH locus. One hundred seventy-two twin pairs were evaluated for sympathetic traits, including catecholamine production, reflex control of the circulation, and environmental (cold) stress responses. To evaluate hypertension, we genotyped subjects selected from the most extreme diastolic blood pressure percentiles in the population. Human TH promoter haplotype/reporter plasmids were transfected into chromaffin cells. Forty-nine single-nucleotide polymorphisms were discovered, but coding region polymorphism did not account for common phenotypic variation. A block of linkage disequilibrium spanned 4 common variants in the proximal promoter. Catecholamine secretory traits were significantly heritable (h2), as were stress-induced blood pressure changes. In the TH promoter, significant associations were found for urinary catecholamine excretion and for blood pressure response to stress. TH promoter haplotype 2 (TGGG) showed pleiotropy, increasing both norepinephrine excretion and blood pressure during stress. Coalescent simulations suggest that TH haplotype 2 likely arose {approx}380 000 years ago. In hypertension, 2 independent case-control studies (1266 subjects with 53% women and 927 subjects with 24% women) replicated the effect of C-824T in the determination of blood pressure.

Conclusions— We conclude that human catecholamine secretory traits are heritable, displaying joint genetic determination (pleiotropy) with autonomic activity and finally with blood pressure in the population. Catecholamine secretion is influenced by genetic variation in the adrenergic pathway encoding catecholamine synthesis, especially at the classically rate-limiting step, TH. The results suggest novel pathophysiological links between a key adrenergic locus, catecholamine metabolism, and blood pressure and suggest new strategies to approach the mechanism, diagnosis, and treatment of systemic hypertension.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
L. Wang, F. Rao, K. Zhang, M. Mahata, J. L. Rodriguez-Flores, M. M. Fung, J. Waalen, M. G. Cockburn, B. A. Hamilton, S. K. Mahata, et al.
Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.
J. Am. Coll. Cardiol., September 1, 2009; 54(10): 944 - 954.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Kvetnansky, E. L. Sabban, and M. Palkovits
Catecholaminergic Systems in Stress: Structural and Molecular Genetic Approaches
Physiol Rev, April 1, 2009; 89(2): 535 - 606.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
K. Zhang, F. Rao, B. K. Rana, J. R. Gayen, F. Calegari, A. King, P. Rosa, W. B. Huttner, M. Stridsberg, M. Mahata, et al.
Autonomic Function in Hypertension: Role of Genetic Variation at the Catecholamine Storage Vesicle Protein Chromogranin B
Circ Cardiovasc Genet, February 1, 2009; 2(1): 46 - 56.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. A. Peralta and M. G. Shlipak
Hypertension in Children With Chronic Kidney Disease: A Call to Action
Hypertension, October 1, 2008; 52(4): 610 - 612.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Rao, L. Zhang, and D. T. O'Connor
Complex Trait Genetics: The Role of Mechanistic "Intermediate Phenotypes" and Candidate Genetic Loci
J. Am. Coll. Cardiol., July 8, 2008; 52(2): 166 - 168.
[Full Text] [PDF]


Home page
HypertensionHome page
P.-a. B. Shih and D. T. O'Connor
Hereditary Determinants of Human Hypertension: Strategies in the Setting of Genetic Complexity
Hypertension, June 1, 2008; 51(6): 1456 - 1464.
[Full Text] [PDF]


Home page
CirculationHome page
D. S. Goldstein
Genotype and Vascular Phenotype Linked by Catecholamine Systems
Circulation, January 29, 2008; 117(4): 458 - 461.
[Full Text] [PDF]


Home page
CirculationHome page
S. C. Hunt
Tyrosine Hydroxylase: Another Piece of the Genetics of Hypertension Puzzle
Circulation, August 28, 2007; 116(9): 970 - 972.
[Full Text] [PDF]